12 results
SC TO-T/A
EX-99
PNT
POINT Biopharma Global Inc.
18 Dec 23
Third party tender offer statement (amended)
6:59am
trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com
SC TO-T/A
EX-99
PNT
POINT Biopharma Global Inc.
4 Dec 23
Third party tender offer statement (amended)
7:04am
that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com
SC TO-T/A
EX-99
PNT
POINT Biopharma Global Inc.
17 Nov 23
Third party tender offer statement (amended)
6:53am
that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com
SC TO-T/A
EX-99
LLY
Lilly(Eli) & Co
15 Nov 23
Third party tender offer statement (amended)
6:51am
clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com
SC TO-T/A
EX-99
PNT
POINT Biopharma Global Inc.
8 Nov 23
Third party tender offer statement (amended)
5:06pm
the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news or follow us
SC TO-T
EX-99
lh5ey liv8w1s5
13 Oct 23
Third party tender offer statement
6:52am
SC TO-C
EX-99.1
g4nk5
3 Oct 23
Information about tender offer
4:30pm
SC14D9C
EX-99.4
6h171go7
3 Oct 23
Written communication relating to third party tender offer
7:37am
8-K
EX-99.4
jt3pzih1un p0r
3 Oct 23
Tender and Support Agreement
7:35am
ARS
wbmbfogc81 rymxgtt
1 May 23
Annual report to shareholders
1:52pm
DEF 14A
ffnowr
28 Apr 22
Definitive proxy
8:36am
- Prev
- 1
- Next